Disease activity is associated with LV dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease

Autor: Punchong Hanvivadhanakul, Adisai Buakhamsri

Publikováno v: Advances in Rheumatology, Vol 59, Iss 1, Pp 1-8 (2019)

Abstract Objectives The cross-sectional study aimed to assess left ventricular systolic function using global longitudinal strain (GLS) by speckle-tracking echocardiography (STE) and arterial stiffness using cardio-ankle vascular index (CAVI) in Thai

Externí odkaz: https://doaj.org/article/0c5203366c0843c085f174db5dc60ae3

Association between depression and sarcopenia in patients with heart failure

Autor: Kornanong Yuenyongchaiwat, Prapromporn Pinijmung, Adisai Buakhamsri

Publikováno v: F1000Research. 11:1093

Background: Prevalence of heart failure has been increasing worldwide. Decreased muscle mass, poor physical activity, and reduced physical performance or muscle strength might lead to sarcopenia among heart failure patients and therefore lead to low

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9fb0b584a159b34140c3f90e07439139
https://doi.org/10.12688/f1000research.125343.1

Physicians' guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry

Autor: Ingrid Hopper, Vasilica Enache, Arintaya Phrommintikul, Lars Kober, Olga Koshelskaya, Asri Said, Juan Francisco Delgado Jiménez, Ruslan Abdullayev, Jonathan Howlett, Attila Frigy, Yury Grinshtein, Sholpan Zhangelova, Oleg Shtegman, Endre Zima, Elena Kosmacheva, Caroline Daly, Sofian Johar, Ruxandra Christodorescu, Kuan Leong Yew, Nathan Dwyer, Sergey Yakushin, Catalin Adrian Buzea, Martin Cowie, Dulce Brito, Albert Galyavich, Gulnara Junusbekova, Sergei Shalaev, Inna Viktorova, Alexandru Nechita, LUIGI TAVAZZI, Wanwarang Wongcharoen, ADISAI BUAKHAMSRI, Joanna Plonka, Svetlana Boldueva, Piotr Ponikowski, Ruslan Najafov, Alexander Kastanayan, Niall Mahon, Dmitry Zateyshchikov, Yury Vasyuk, George Giannakoulas, Ewa Lewicka

Publikováno v: Komajda, M, Schöpe, J, Wagenpfeil, S, Tavazzi, L, Böhm, M, Ponikowski, P, Anker, S D, Filippatos, G S, Cowie, M R & QUALIFY Investigators 2019, ' Physicians' guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction : the QUALIFY international registry ', European Journal of Heart Failure, vol. 21, no. 7, pp. 921-929 . https://doi.org/10.1002/ejhf.1459

Background Physicians’ adherence to guideline-recommended therapy is associated with short-term clinical outcomes in heart failure (HF) with reduced ejection fraction (HFrEF). However, its impact on longer-term outcomes is poorly documented. In thi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a8584353e5f6600a517294bd4520dc0
https://pubmed.ncbi.nlm.nih.gov/31099172

Left Atrial Strain Measured by Two-Dimensional Speckle Tracking Represents a New Tool to Evaluate Left Atrial Function

Autor: Zoran B. Popović, Adisai Buakhamsri, Allan L. Klein, Neil L. Greenberg, Sayit Demirkol, James D. Thomas, Roberto M. Saraiva

Publikováno v: Journal of the American Society of Echocardiography. 23:172-180

Background Left atrial (LA) strain (e) and e rate (SR) analysis by two-dimensional speckle tracking can represent a new tool to evaluate LA function. To assess its potential value, the authors addressed whether LA e and SR measured in normal subjects

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8e09aa9240ec1357b692798036558c0b
https://doi.org/10.1016/j.echo.2009.11.003

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial

Autor: Gilmar Reis, Jose Nicolau, Andrzej Rynkiewicz, Simon Jones, Giovanni ESPOSITO, Konstantin Ramshev, James Spratt, Marco Vugman Wainstein, Miguel Urina, Furio Colivicchi, Legkonogov Aleksandr, Yury Shvarts, Carole Siegel, Yury Grinshtein, Diana Gorog, Ricardo Bohorquez, Alexander Joost, Aldo Pietro Maggioni, Peter Sinnaeve, Crina Julieta Sinescu, Prof. Dr. Ahmed Nahhas, Judith Hochman, Leszek Gromadziński, Catalina Arsenescu Georgescu, Mónica Jaramillo, Nattawut Wongpraparut, Filipa Costa, Yaroslav Malynovsky, Philippe Gabriel STEG, Gianluca Campo, Vladimir Zadionchenko, Andreas Zirlik, Jerome Chin, Wolfram Goessling, Daniel Pella, Roman Libis, Ivo Petrov, Giuseppe Giugliano, Glenn Hamroff, Sergei Shalaev, Amos Katz, Meyer ELBAZ, Peter Ganz, Martha Sarno, Wolfgang Koenig, ADISAI BUAKHAMSRI, Marco Valgimigli, Simcha Meisel, Svetlana Boldueva, K Srinath Reddy, FRANCISCO FUENTES JIMENEZ, Raúl J. Gazmuri, Philip Aylward, Albert Vernon Smith, Fernando Manzur, Dmitry Zateyshchikov, Zuyi Yuan, William Wijns, Arman Postadzhiyan, Arun Chopra, Andrzej Budaj, Pablo Olavegogeascoechea, Emilia Solinas

Publikováno v: JAMA-Journal of the American Medical Association, 312(10), 1006-1015. American Medical Association
JAMA, 312(10), 1006-1015. American Medical Association
JAMA : the journal of the American Medical Association

IMPORTANCE: Lipoprotein-associated phospholipase A2 (Lp-PLA2) has been hypothesized to be involved in atherogenesis through pathways related to inflammation. Darapladib is an oral, selective inhibitor of the Lp-PLA2 enzyme. OBJECTIVE: To evaluate the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1e3aa462792e6e3513431e7f9c25697
https://pubmed.ncbi.nlm.nih.gov/25223450